Nanopolyphenols: Perspective on oxidative stress-induced diseases

Recently nanopolyphenols are gaining widespread interest in the drug discovery domain. Nanonization of polyphenols has greatly affected the therapeutic index owing to improvement in pharmacokinetic and biopharmaceutical obstacles linked with the use of natural polyphenols. They have been looking at...

Full description

Bibliographic Details
Main Authors: Priyanka Rathod, Raman P Yadav
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:MGM Journal of Medical Sciences
Subjects:
Online Access:http://www.mgmjms.com/article.asp?issn=2347-7946;year=2022;volume=9;issue=3;spage=419;epage=430;aulast=Rathod
_version_ 1797995510857990144
author Priyanka Rathod
Raman P Yadav
author_facet Priyanka Rathod
Raman P Yadav
author_sort Priyanka Rathod
collection DOAJ
description Recently nanopolyphenols are gaining widespread interest in the drug discovery domain. Nanonization of polyphenols has greatly affected the therapeutic index owing to improvement in pharmacokinetic and biopharmaceutical obstacles linked with the use of natural polyphenols. They have been looking at an emerging paradigm for an array of disease symptoms. In this article, we have explored the therapeutic potential of nanopolyphenols in oxidative stress-induced diseases such as neurodegeneration, cancer, obesity, and diabetes. This article will present the current state of the art of various nanopolyphenols targeting oxidative stress-induced diseases. The advanced fabrication strategies presented for polyphenols including nanocrystal, mesoporous silica nanoparticles, nanoparticles, nanoliposome, gold nanoparticle, and nanosuspension are discussed. The information presented in light of recent in vitro, in vivo, and clinical evidence for nanoformulation and delivery of polyphenols may show a new dimension to future research in the realm of herbal therapy for oxidative stress-induced diseases. Significant information on the molecular mechanisms underlying linkages of oxidative stress with neurodegenerative diseases, cancer, obesity, and diabetes is discussed. Valuable information on dietary polyphenols in these diseases and their clinical data is presented. Based on different experimental evidence, the review findings support phenomenal therapeutic strategies for nanopolyphenolic fabrication with extended benefits and a condensed time frame. The status of clinical trials conducted on nanopolyphenols is presented. Although clinical trials conducted on nanopolyphenols for mentioned diseases are few, we have tried to present as much available clinical data in this article.
first_indexed 2024-04-11T10:02:54Z
format Article
id doaj.art-6980dc4240f448538e7a5fb23a13ae91
institution Directory Open Access Journal
issn 2347-7946
2347-7962
language English
last_indexed 2024-04-11T10:02:54Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series MGM Journal of Medical Sciences
spelling doaj.art-6980dc4240f448538e7a5fb23a13ae912022-12-22T04:30:20ZengWolters Kluwer Medknow PublicationsMGM Journal of Medical Sciences2347-79462347-79622022-01-019341943010.4103/mgmj.mgmj_100_22Nanopolyphenols: Perspective on oxidative stress-induced diseasesPriyanka RathodRaman P YadavRecently nanopolyphenols are gaining widespread interest in the drug discovery domain. Nanonization of polyphenols has greatly affected the therapeutic index owing to improvement in pharmacokinetic and biopharmaceutical obstacles linked with the use of natural polyphenols. They have been looking at an emerging paradigm for an array of disease symptoms. In this article, we have explored the therapeutic potential of nanopolyphenols in oxidative stress-induced diseases such as neurodegeneration, cancer, obesity, and diabetes. This article will present the current state of the art of various nanopolyphenols targeting oxidative stress-induced diseases. The advanced fabrication strategies presented for polyphenols including nanocrystal, mesoporous silica nanoparticles, nanoparticles, nanoliposome, gold nanoparticle, and nanosuspension are discussed. The information presented in light of recent in vitro, in vivo, and clinical evidence for nanoformulation and delivery of polyphenols may show a new dimension to future research in the realm of herbal therapy for oxidative stress-induced diseases. Significant information on the molecular mechanisms underlying linkages of oxidative stress with neurodegenerative diseases, cancer, obesity, and diabetes is discussed. Valuable information on dietary polyphenols in these diseases and their clinical data is presented. Based on different experimental evidence, the review findings support phenomenal therapeutic strategies for nanopolyphenolic fabrication with extended benefits and a condensed time frame. The status of clinical trials conducted on nanopolyphenols is presented. Although clinical trials conducted on nanopolyphenols for mentioned diseases are few, we have tried to present as much available clinical data in this article.http://www.mgmjms.com/article.asp?issn=2347-7946;year=2022;volume=9;issue=3;spage=419;epage=430;aulast=Rathodantioxidantcancerdiabetesnanopolyphenolsneurodegenerationobesityoxidativestress
spellingShingle Priyanka Rathod
Raman P Yadav
Nanopolyphenols: Perspective on oxidative stress-induced diseases
MGM Journal of Medical Sciences
antioxidant
cancer
diabetes
nanopolyphenols
neurodegeneration
obesity
oxidative
stress
title Nanopolyphenols: Perspective on oxidative stress-induced diseases
title_full Nanopolyphenols: Perspective on oxidative stress-induced diseases
title_fullStr Nanopolyphenols: Perspective on oxidative stress-induced diseases
title_full_unstemmed Nanopolyphenols: Perspective on oxidative stress-induced diseases
title_short Nanopolyphenols: Perspective on oxidative stress-induced diseases
title_sort nanopolyphenols perspective on oxidative stress induced diseases
topic antioxidant
cancer
diabetes
nanopolyphenols
neurodegeneration
obesity
oxidative
stress
url http://www.mgmjms.com/article.asp?issn=2347-7946;year=2022;volume=9;issue=3;spage=419;epage=430;aulast=Rathod
work_keys_str_mv AT priyankarathod nanopolyphenolsperspectiveonoxidativestressinduceddiseases
AT ramanpyadav nanopolyphenolsperspectiveonoxidativestressinduceddiseases